O. S. Afonina

O. S. Afonina

Auto-generated profile, based on publicly available information

O. S. Afonina

National Medical Research Center for Therapy and Preventive Medicine; Sklifosovsky Research Institute for Emergency Medicine

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2024 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
SMS. Yu. Martsevich
S. Yu. Martsevich
OAO. S. Afonina
O. S. Afonina
АЗА. В. Загребельный
А. В. Загребельный
DSD. P Sichinava
D. P Sichinava
ISI. V. Samorodskaya
I. V. Samorodskaya
СМС. Ю. Марцевич
С. Ю. Марцевич
Aim. To compare the long-term prognosis of life of patients after primary and recurrent acute myocardial infarction (MI).Material and methods. The study was based on the RIMIS registry, which included all patients after transmural MI in 2017 in one of the Moscow vascular centers. The prospective part included 191 patients who survived the acute stage of MI, of which 145 suffered a primary acute MI, 46 — a recurrent acute MI. Long-term follow-up data were collected 71 (53;75) months after discharge from the hospital. The primary endpoint was any-cause death.Results. During the follow-up period, 35 (25,2%) patients with a primary MI and 25 (64,1%) patients with a recurrent MI died (p<0,001). It was not possible to establish the fate of 13 (6,81%) patients, of which 7 (4,83%) were people with primary MI and 6 (13,04%) people with recurrent MI. The death risk was significantly higher in patients who had a recurrent MI compared to patients who had a primary MI: hazard ratio (HR)=3,52 (2,09;5,96), p<0,001). An unfavorable prognosis was determined not by the fact of a recurrent MI, but by the complications that resulted from a previous MI, primarily heart failure, as well as age, sex, smoking status, and hospitalizations for cardiovascular diseases in the year before the reference MI, history of angina and following comorbidities: a prior stroke, major bleeding (life-threatening gastrointestinal bleeding requiring complex surgical intervention). Patients who had a recurrent MI were significantly more adherent to follow-up and prescribed therapy.Conclusion. Despite the modern strategy for treating MI both in the acute stage and in the long-term period, the prognosis after recurrent MI remains unfavorable. Signs negatively affecting the prognosis were sex, age, a history of heart failure and angina pectoris, and hospitalizations for cardiovascular diseases one year prior to reference MI.

5 February 2024 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
SMS. Yu. Martsevich
S. Yu. Martsevich
AZA. V. Zagrebelnyy
A. V. Zagrebelnyy
OAO. S. Afonina
O. S. Afonina
IKI. M. Kuzmina
I. M. Kuzmina
YAYu. V. Avdeev
Yu. V. Avdeev
ODOxana M. Drapkina
Oxana M. Drapkina
Aim. To study the features of the course of primary and recurrent myocardial infarction and compare their prognosis in the acute stage of the disease within the framework of the hospital register of the vascular center.Material and methods. The data from the acute coronary syndrome register of N. V. Sklifosovsky Research Institute for Emergency Medicine were used. The inclusion criteria were: transmural acute myocardial infarction (AMI) with ST-segment elevation (codes I21.0-I21.3 according to the International Classification of Diseases); permanent residence in Moscow and the Moscow region. The described part of the study included all patients with transmural myocardial infarction (codes I21.0-I.21.3) admitted from January 1, 2017 to December 31, 2017. Of the AMI patients admitted during this period (n=329), 214 met the inclusion criteria, with primary AMI in 153 and recurrent AMI in 61.Results. Patients with recurrent AMI were significantly older, more often had a disability group. Smoking and arterial hypertension were more frequent risk factors among patients with recurrent AMI than in primary AMI. All indices reflecting the severity of coronary artery disease and its complications were also significantly more common in the group with recurrent AMI. Diabetes mellitus was more common in these patients. Taking medications before hospitalization, as well as the regularity of this intake, were significantly more common in patients who had repeated AMI. The mortality rate of patients with recurrent AMI was 4.6 times higher than that of patients with primary AMI. Such complications as atrial fibrillation and flutter, intracardiac conduction disturbance requiring temporary endocardial stimulator placement, acute heart failure requiring intra-aortic balloon counterpulsation, respiratory failure requiring artificial ventilation, cardiogenic shock were significantly more common in patients with recurrent AMI. Kaplan-Meyer curves clearly demonstrate the differences in hospital mortality among the two groups of patients. These curves also clearly show that patients with primary AMI died mostly in the first days of the disease, but patients with recurrent AMI could die at a much later date, up to 12 days after admission. Analysis of factors determining the mortality risk during hospitalization showed that recurrent AMI is an independent predictor of death.Conclusion. The results of our work indicate the need for prompt identification of patients who had previously undergone AMI upon their admission to the vascular center, as well as the development of more active prevention tactics for such patients.

22 September 2024 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
SMS. Yu. Martsevich
S. Yu. Martsevich
АЗА. В. Загребельный
А. В. Загребельный
NZN. P. Zolotareva
N. P. Zolotareva
MGM. L. Ginzburg
M. L. Ginzburg
ИКИ. М. Кузьмина
И. М. Кузьмина
СМС. Ю. Марцевич
С. Ю. Марцевич
Aim. To compare the long-term survival of patients after primary and recurrent myocardial infarction (MI) in the LIS-3 and RIMIS registries.Material and methods. The retrospective RIMIS registry included patients with acute transmural MI admitted to the emergency cardiology department of one of the Moscow vascular centers in 2017. A total of 214 patients were included, of which 23 people died in hospital and 191 people were included in the prospective registry part. Long-term vital status was assessed on average 6 years after discharge from hospital and was determined in 178 patients. The response rate was 93,19%. The prospective registry LIS-3 included all patients admitted to the Lyubertsy Regional Hospital with a diagnosis of acute coronary syndrome, of which 78 patients were discharged after confirmed MI in the first 9 months of 2014, and 164 patients were discharged after confirmed MI in the first 9 months of 2018. A total of 242 patients were included. Long-term vital status was determined in 207 patients. The response rate 85,5%. The median follow-up was 872 days. Comparative analysis of patient cohorts from the RIMIS and LIS-3 registries did not reveal any significant differences in the main demographic, anamnestic, and clinical parameters. The frequency of percutaneous coronary intervention in the acute stage of MI was higher in the RIMIS registry than in the LIS-3 registry (96,9 and 62,3%, respectively).Results. During the follow-up period, 31,4% of patients died in the RIMIS registry, and 20,8% of patients in the LIS-3 registry. Kaplan-Meier curves did not reveal any significant differences in patient survival in both registries. At the same time, in both registries, the long-term survival of patients after recurrent MI was significantly worse than that of patients who had a primary MI.Conclusion. Patients who had an acute MI, despite modern treatment in the acute stage, have a high residual risk of death. This is especially true for patients who had a recurrent MI.

1 December 2024 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
OAO. S. Afonina
O. S. Afonina
SMS. Yu. Martsevich
S. Yu. Martsevich
AZA. V. Zagrebelnyy
A. V. Zagrebelnyy
DSD. P. Sichinava
D. P. Sichinava
ODOxana M. Drapkina
Oxana M. Drapkina
Aim. Among patients who survived acute myocardial infarction (MI) with ST segment elevation (STEMI), to assess gender differences in clinical and anamnestic indicators, long-term survival, as well as factors affecting it. To compare the effect of recurrent MI on long-term survival in men and women.Material and methods. Data from the retro-prospective RIMIS register were used. In 2017, 214 patients with STEMI were admitted to the emergency cardiology department of the vascular center, 23 (10.8%) of them died in the hospital. After 6 years, the life status of patients discharged from the hospital was assessed (191 people, 129 men, 62 women). The response was 93.2%. The factors influencing the fatal outcome were assessed using a model of proportional Coke risks separately for men and women. The primary endpoint was the overall patient’s mortality.Results. The women who survived MI were, on average, 16.5 years older than the men who survived, and they were more likely to have concomitant diseases (diabetes mellitus, obesity). During the follow-up period, 34 men (26.4%) and 26 women (41.9%) died. Kaplan-Meyer curves demonstrated significantly worse survival in women compared to men. However, after the age adjustment was introduced, the risk of death in women was lower than in men (HR =0.981 (0.968-0.993), p=0.003). The main mortality predictors in women were hospitalization before reference MI, a history of coronary heart disease, a history of cerebral stroke, and anemia. In men, the main predictor of death was the presence of disability, the fact of recurrent MI, a history of chronic kidney disease and the presence of oncology (the latter two factors were rare, respectively, in 6.2% and 3.9% of patients).Conclusion. Women suffered MI much later than men. Therefore, higher mortality rates after MI were mainly determined by concomitant diseases. The main mortality predictor in men was recurrent MI. The age-adjusted risk of death after MI is lower in women than in men.

30 June 2025 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
SMS. Yu. Martsevich
S. Yu. Martsevich
NKN. P. Kutishenko
N. P. Kutishenko
EKE. P. Kalaydzhyan
E. P. Kalaydzhyan
YLYulia Lukina
Yulia Lukina
AZA. V. Zagrebelnyy
A. V. Zagrebelnyy
ODOxana M. Drapkina
Oxana M. Drapkina
This article addresses the issue of refusal of pharmacological treatment. Limited literature data concerning the clinical significance of treatment refusal in patients with internal organ diseases are presented. Original foreign studies focusing on treatment refusal in patients with chronic non-communicable diseases, particularly those with cardiovascular conditions, are rare. Most of these studies examine not only the refusal to take medications but also the discontinuation of specific therapeutic procedures, as well as the underlying reasons for such refusals. An analysis was conducted of Russian prospective clinical registries for cardiovascular diseases, which have recorded instances of complete cessation of pharmacological therapy or the phenomenon of absolute non-adherence. The frequency of complete discontinuation of treatment ranged from 1% to 10.1%. The main reasons for the complete discontinuation of medication included satisfactory health status, reluctance to engage in prolonged medication use, and high costs associated with treatment. It is demonstrated that complete discontinuation of therapy may have a negative impact on disease outcomes. Thus, a certain proportion of patients with cardiovascular diseases completely refuse treatment, despite being provided with recommendations. This can be partly attributed to the patients’ relatively good well-being. Additionally, poor awareness regarding the efficacy of prescribed medications seemingly plays a significant role. Therefore, a promising approach to prevent the phenomenon of absolute non-adherence among patients with chronic non-communicable diseases is regular monitoring and educating them about the fact that the prescribed therapy can not only alleviate disease symptoms but also improve the prognosis and reduce the risk of complications.

13 September 2022 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
OAO. S. Afonina
O. S. Afonina
ИКИ. М. Кузьмина
И. М. Кузьмина
АЗА. В. Загребельный
А. В. Загребельный
LKL. S. Kokov
L. S. Kokov
SMS. Yu. Martsevich
S. Yu. Martsevich
СМС. Ю. Марцевич
С. Ю. Марцевич
An important place in the structure of cardiovascular morbidity is occupied by myocardial infarction (MI), especially complicated MI, including complicated by the formation of left ventricular (LV) aneurysm. The latter is a very formidable complication and leads to such life-threatening conditions as ventricular arrhythmias, heart failure, thromboembolism. The purpose of the review is to analyze the publications of foreign and Russian authors on risk factors, outcomes and treatment of patients with postinfarction LV aneurysm. Attention is paid to the role of registers in the study of this problem, as well as the analysis of literature data on the prevalence of such a complication as MI during the COVID-19 pandemic (COrona VIrus Disease 2019). It is shown that the registers of acute coronary syndrome, as a rule, do not contain separate data on patients with a formed LV aneurysm, risk factors for its development and outcomes in this group of patients. Postinfarction LV aneurysm can form only after transmural MI; therefore, it is important to keep records of patients diagnosed with transmural MI, primarily in the form of a register.